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CREATING A CULTURE OF ONGOING LEARNING
Frith, J.L.1, Adler, A.2 1Duke University, Durham, NC; 2Duke Univer-
sity, Durham, NC
Orientation programs exist for nurses in all clinical areas. For
the hematopoietic stem cell transplant (HSCT) specialty, an ex-
tensive orientation program has been developed for newer nurses
to obtain a wealth of knowledge within the specialty. In the
HSCT day hospital, the turnover rate is historically very low.
While nurses were oriented upon initial employment, continuing
educational opportunities were miminal, as the day hospital is
off-site from the academic center. It was evident that employees
were unaware and felt unable to attend continuing education due
to the staffing challenges.
As transplants are better understood, and utilized in patients
with different disease processes and more comorbidities, the acu-
ity becomes higher in the outpatient environment. It is therefore
imperative that nurses are prepared to critically care for this
more acutely ill patient population through assessment and ap-
propriate interventions. A HSCT nurse education program was
developed for the outpatient staff to include opportunities for
nurses to obtain specific needed education to maintain compe-
tence on current care and issues within HSCT. In developing
the program, education style and preference were assessed. The
Nurse Manager reviewed courses offered through the health sys-
tem and determined courses that were relevant for each nurse to
take. The Clinical Nurse Specialist provided insight into the
long-term vision of the HSCT program. Developing a successful
ongoing education program for experienced nurses that engages
the nurses is vital to the success of this unique clinic.
Thirty classes were identified as necessary for continued compe-
tence. Prior to scheduling staff for continuing education 31% of
the classes had been attended within the past 5 years. In advance,
scheduling was accommodated to ensure staff was able to attend clas-
ses away from work. Since implementation (6 months ago), 42% of
the classes has been attended with staff reporting appreciation of
the opportunities offered. The staff has expressed a rejuvenated in-
terest in continuing education, and is now exploring further oppor-
tunities on their own. This has also translated into staff being more
aware, and providing further evidenced-based education to patients
and their caregivers. Nurses that are involved, engaged, and take
ownership of their education will have a positive effect on their en-
vironment and others. Having nurses and leadership involved will
help create a culture of ongoing learning.517
INCREASE HCAHPS SCORES IN AUTOLOGOUS STEM CELL TRANSPLANT
PATIENTS AT CLEVELAND CLINIC
Cherni, K., Ferraro, C., Green, G., Weber, C., Kalaycio, M. Cleveland
Clinic, Cleveland, OH
The Bone Marrow Transplant (BMT) Program at Cleveland
Clinic (CC) prides itself with a ‘Patients First’ mantra.We have built
a multidisciplinary staff to support and educate patients throughout
their transplant process. Education binders are mailed to patients af-
ter their consult with a transplant physician. This binder contains ed-
ucational material to assist patients and caregivers throughout the
transplant process. The BMT nurse coordinators meet with patients
and caregivers many times during the transplant process to educate,
review and reinforce the educational material.
Prior to discharge, patients and caregivers have always been edu-
cated about post-transplant care, including the use of medications
for symptom management. We recently chose to improve the pro-
cess of medication communication to improve patient safety and sat-
isfaction.
Beginning July 7th, 2011 the following changes were made to our
autologous discharge protocol: 1) The BMT PharmD creates and
reviews with the patient and family, a ‘MedAction’ form that in-
cludes each discharge medication. The form includes generic and
brand names, dose, frequency, and the rationale for each medica-
tion. Medications for symptom management, often prescribed ‘as
needed’, are especially important and often the directions can beconfusing for patients. 2) Caregivers obtain discharge medications
from the pharmacy to allow the PharmD and the inpatient nurse
to’re-review’ the actual dispensed medication. These changes will
help decrease confusion about new medications and should increase
medication communication and compliance. 3) Autologous BMT
patients are to be scheduled in the outpatient clinic for labs and
possible treatment 2-3 days after discharge in lieu of having labs
drawn near home. This gives patients and their nurse an opportu-
nity to assess symptoms, discuss questions and concerns, and to re-
view medications.
Table. Hospital Consumer Assessment of Healthcare Pro-
viders and Systems (HCAHPS) Scores for BMT Unit
Cleveland Clinic2007 2008 2009 2010July and
August 2011Goal thru 3rd
Quarter 2011Medication
Communication71% 63% 65% 70% 75% 68%Hospital Environment 55% 47% 60% 64% 67% NAResponsiveness 49% 58% 62% 67% 68% 73%Nurse
Communication86% 79% 82% 81% 79% 81%Doctor
Communication86% 74% 81% 73% 73% 86%Discharge 87% 89% 97% 94% 92% 88%Pain Management 78% 73% 78% 71% 72% 76%Overall Assessment 79% 64% 86% 80% 79% 80%As indicated in the table, our HCAHPS scores for medical com-
munication have increased from 70% to 75% since our plan was im-
plemented. The table displays the percentage of respondents who
reply ‘‘Always’’ to the question about medical communication in
the survey instrument.
We conclude that multidisciplinary process improvements to
patient instructions and education improve patient satisfaction as
reflected in post-discharge surveys.518
RITUXIMAB AND PPE: TO WEAR OR NOT TO WEAR? THAT IS THE
QUESTION
Brown, S.L. MD Anderson Cancer Center, Houston, TX
On the stem cell transplant (SCT) unit of a large comprehen-
sive cancer center, current policy requires staff wear personal
protective equipment (PPE) when administering drugs considered
hazardous by Centers for Disease Control (CDC) and National
Institute for Occupational Safety and Health (NIOSH) guide-
lines. Rituximab, a monoclonal antibody drug used as part of
conditioning regimens for stem cell transplantation, falls under
these guidelines. Each dose is administered over 4 to 8 hours
and requires extensive monitoring, including frequent vital signs,
rate changes, and assessment of the patient. Adorning PPE each
time the nurse enters a patient’s room becomes both time con-
suming and costly.
To address this issue, a group of nurses developed an evidenced-
based work group to evaluate if the use of PPE was necessary
when administering Rituximab. The group consulted the literature,
obtained data on the cost of PPE, average infusion times, and iden-
tified the average number of times a room was entered during Ritux-
imab administration.
The group found the average length of infusion was 4.8 hours,
with 18.5 approaches, and the use of 1.7 chemotherapy/biother-
apy gowns. The average cost of PPE per administration is
$75.98, not considering specific isolation restrictions or the
need to enter the room more often. Reviewing the literature,
CDC and NIOSH guidelines revealed that Rituximab is not con-
sidered a hazardous drug and has no adverse health effects
through eye, skin, or mucous membrane contact (Genentech,
2011). In fact, the Genentech Company, producer of Rituximab,
reports no special first aid measures are required after exposure
of the drug except hand washing.
Poster Session II S393The literature suggests that PPE use when administering Rit-
uximab is unnecessary. Eliminating this practice will potentially
save the institution both time and money. These findings have
led the group to propose a clinical practice change to the insti-
tution’s nursing practice congress. Results will be shared in the
final presentation, including specific cost savings information.
Reference: Genentech USA, Inc. (2011). Rituxan. Retrieved from:
www.gene.com/gene/products/information/oncology/rituxan.519
STEM CELL TRANSPLANT NURSING: THE OTHER SIDE OF THE CENTER
Tomczak, N.D., Blackburn, R. The University of Texas MD Anderson
Cancer Center, Houston, TX
Maintaining consistency across the continuum of care in large
stem cell transplant (SCT) centers can be very challenging. Staff
who are exposed to patients during only one aspect of the process
can often deliver inconsistent information and often experience com-
passion fatigue. In an institution that does over 700 transplants in
a year with 64 inpatient beds and several outpatient clinics, an outpa-
tient shadowing program was implemented to address some of the
rising concerns.
Inpatient SCT nurses were provided with the opportunity to
spend a shift shadowing individuals and observing care in various
outpatient areas. Time was spent with clinic nurses, SCT coordina-
tors, business access specialists, and others. In addition, nurses were
able to observe patient care in the outpatient SCT Auto, Allo, and
Survivorship clinics. The goal of the shadowing experience was to
develop a better understanding of each step of the complex SCTpro-
cess and to boost morale by seeing patients who had successfully
been discharged post transplant.
Over a span of 3 months, fifty percent of the inpatient nurses were
able to participate in the program. Nursing experience ranged from
less than a year to greater than ten years of SCT nursing experience.
Eighty percent of those participating had never spent time in the out-
patient areas. All participants reported that they found the experi-
ence beneficial to their practice as an SCT nurse. Many
commented that it was a morale booster to see healthy, post trans-
plant patients, and that the experience provided them with a better
understanding of the various roles that are part of the SCT process.
Participation in the program provided nurses exposure to other
areas in the SCT center and the opportunity to better understand
all aspects of the process. The experience helped nurses to see be-
yond their piece of the process, observe patients who had successfully
come through transplant, and provided them with information
needed to better educate patients and families.520
IMPROVING NUTRITION IN ADULT HEMATOPOIETIC STEM CELL
TRANSPLANT PATIENTS THROUGH INTERNATIONAL COLLABORATION
BY ENGAGING PATIENTS, STAFF AND FAMILIES
Bayliss, C.1, Holmberg, K.2, Kornegay-Shaw, S.1, Fisher-Streno, P.1
1Duke University Hospital, Durham, NC; 2Karolinska University Hospi-
tal, Sweden
Nutrition is a key factor in the hospitalization of adult Hemato-
poietic Stem Cell Transplant patients (HSCT). Many patients expe-
rience reduced oral intake due to pre-aversions about hospital food
or fear related to eating during the transplant process. This may
have a negative impact on the outcome after transplant. A Danish
study showed that patients receiving nutritional support froma nutri-
tion team had better oral intake, less side effects and a shorter hospi-
tal stay (Johansen N, Kondrup J, Plum Munk L et al Clinical
Nutrition 2004). Recently, our department had a unique opportunity
to visit a European transplant center and found this to be true.
Physicians routinely collaborate with international colleagues.
Nurses have not sought as many opportunities for international col-
laboration due to barriers including differences in health care sys-
tems, medications used and language. We are working to
overcome these barriers. Through the inter-disciplinary communi-
cation that we have experienced thus far, we have noticed great ben-
efit from this collaboration.By having the opportunity to collaborate on the international
level with colleagues regarding HSCT patient nutrition, we
have found that there are many options to enhance the nutri-
tional status of our patients. Our European colleagues have
used the following tactics to improve the nutritional status of pa-
tients: 1) entice patients to get adequate nutrition 2) educate pa-
tients and caregivers in the value of proper nutrition and 3)
consistently assess baseline nutrition issues that may impact re-
covery after transplant. After learning about how our fellow
nurses implemented these methods into their daily routine, we
began to develop a plan to better the nutritional health of our
patients. By working together, we have used presentation, educa-
tion and collaboration to enhance our patients’ nutritional status.
Our presentation will share the tools we have used, the data from
our facility as well as our European colleagues and future ideas
for collaboration across the continents.
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THE IMPACT OF THE CARE MANAGER IN A PATIENT EMPOWERED
CARE MODEL (PEC) OF INTEGRATED CARE ON HSCT PATIENTS EXPE-
RIENCE
Short, L.A., Leone, N., Doyle, E. Cancer Treatment Centers of America @
Midwestern Regional Medical Center, Zion, IL; Cancer Treatment Cen-
ters of America @ Midwestern Regional Medical Center, Zion, IL; Cancer
Treatment Centers of America @ Midwestern Regional Medical Center,
Zion, IL
Care Management, is a vital part of the PEC team, impacting the
care continuum of patients receiving hematopoietic stem cell trans-
plant (HSCT). The multiple aspects of this role and the impact on
patient follow up and early intervention of patient issues will be de-
scribed. The interaction with other members of the team will also be
discussed.
It has been said that knowledge is power. But for a person facing
a diagnosis of cancer, too much knowledge absorbed in a short pe-
riod of time often can create the opposite of power: a profound
sense of weakness and confusion. Adding to the patient’s stress is
the necessity to undergo a crash course in medical terminology
that is completely foreign to them. And nowhere is this more prev-
alent than in the area of hematopoietic stem cell transplant
(HSCT).
HSCT has continued to expand and evolve as a treatment for he-
matologic malignancies, as well as non- malignant disorders and cer-
tain solid tumors. Each year, more innovative and advanced
methodologies have developed for the use of HSCT. Effective em-
ployment of these treatment options requires comprehensive man-
agement from a multidisciplinary team. And, of course, the
increasing complexity of treatment and the numerous treatment op-
tions available can be overwhelming for our HSCT patient popula-
tion.
One proven solution for patient information overload is the Pa-
tient Empowered CareModel (PEC). PEC is an integrative model
of practice care delivery that unites both traditional and complemen-
tary medicine in an approach to meet the many needs of HSCT pa-
tients. PEC is a natural outgrowth of the Mother Standard, which
from the beginning has been designed to inform and treat our pa-
tients as we would our own mothers. To make this work, team en-
gagement must begin at the moment the patient presents for
consultation, and the Care Manager, alongside the patient, is at
the center of this team. The supportive environment has resulted
in demonstrated positive outcomes as is illustrated by our Health
Grades Awards and positive patient feedback.522
DEVELOPMENT AND IMPLEMENTATION OF PLERIXAFOR PLUS G-CSF
MOBILIZATION ALGORITHM FOR AUTOLOGOUS STEM CELL TRANS-
PLANT (ASCT) IN MULTIPLE MYELOMA (MM) PATIENTS TREATED AT
MEMORIAL SLOAN-KETTERING CANCER CENTER (MSKCC)
Collum, K.A., McCullagh, E. Memorial Sloan Kettering Cancer Center,
New York, NY
Background: The use of Plerixafor plus G-CSF for mobilization in
ASCT patients has historically been used as second line therapy,
